
Emilia Bagiella, PhD
About Me
Dr. Bagiella is Professor of Biostatistics in the Center for Biostatistics in the Department of Population Health Science & Policy at Mount Sinai School of Medicine. She also serves as Director, Biostatistics, Epidemiology and Research Design (BERD), at the MSSM CTSA, CONDUITS. She is Director of the “Reach for the First R01” and “Reach for the first K” course within CONDUITS. She has extensive experience in clinical trial methodology and the design and analysis of longitudinal studies. She also has a methodological interest in outcome assessment and the issues related to evaluating outcomes in different populations. She has served as a DSMB member for clinical trials in Neurology, Cardiology and HIV.
Language
Position
About Me
Dr. Bagiella is Professor of Biostatistics in the Center for Biostatistics in the Department of Population Health Science & Policy at Mount Sinai School of Medicine. She also serves as Director, Biostatistics, Epidemiology and Research Design (BERD), at the MSSM CTSA, CONDUITS. She is Director of the “Reach for the First R01” and “Reach for the first K” course within CONDUITS. She has extensive experience in clinical trial methodology and the design and analysis of longitudinal studies. She also has a methodological interest in outcome assessment and the issues related to evaluating outcomes in different populations. She has served as a DSMB member for clinical trials in Neurology, Cardiology and HIV.
Language
Position
Education
Laurea, Universita' degli studi
MS, Columbia University
PhD, Columbia University
Locations
Publications
Selected Publications
- Amiodarone Prophylaxis against postoperative atrial fibrillation in off-pump coronary artery bypass. Jaskirat Gill, Ami G. Shah, Gabriele Di Luozzo, Julie Mei, Justin Carale, Kristy Huang, Anna S. Mueller, Marcelina Victory-Stewart, Seana Friedman, Emilia Bagiella, Omar Lattouf, John D. Puskas, Mekeleya Yimen, Himani V. Bhatt. Heart and Lung
- Handling non-ignorable missing intimal hyperplasia data – Lessons from the VEST trial. Jessica R. Overbey, Samantha Raymond, Helena Chang, Emilia Bagiella. Contemporary Clinical Trials
- Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): Study protocol of a randomised, double-blind, placebo-controlled trial. Valeria Santibanez, Aditi Mathur, Jigna Zatakia, Nicole Ng, Michele Cohen, Emilia Bagiella, Stacey Ann Brown, Ivan O. Rosas, Nina M. Patel, Amy Olson, Peide Li, Maria Padilla. BMJ Open Respiratory Research